P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

P08-06 LB. A genome-wide association study of host genetic determinants of T cell responses to the MRKAd5 HIV-1 gag/pol/nef vaccine in the STEP trial

Bibliographic Details
Main Authors:	Frahm N, Geraghty DE, Casimiro DR, McElrath J, Cirulli ET, Shianna KV, Fellay J, Goldstein DB
Format:	Article
Language:	English
Published:	BMC 2009-10-01
Series:	Retrovirology

Similar Items

MRKAd5 HIV-1 Gag/Pol/Nef vaccine-induced T-cell responses inadequately predict distance of breakthrough HIV-1 sequences to the vaccine or viral load.
by: Holly Janes, et al.
Published: (2012-01-01)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins
by: Brumme, Zabrina L., et al.
Published: (2010)

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.
by: Zabrina L Brumme, et al.
Published: (2009-08-01)

Predictors of HVTN 503 MRK-AD5 HIV-1 gag/pol/nef vaccine induced immune responses.
by: Kathryn L Hopkins, et al.
Published: (2014-01-01)

OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
by: Self SG, et al.
Published: (2009-10-01)

A Phase I Double Blind, Placebo-Controlled, Randomized Study of the Safety and Immunogenicity of an Adjuvanted HIV-1 Gag-Pol-Nef Fusion Protein and Adenovirus 35 Gag-RT-Int-Nef Vaccine in Healthy HIV-Uninfected African Adults.
by: Gloria Omosa-Manyonyi, et al.
Published: (2015-01-01)

P19-32. HIV-1 vaccine design based on human vaccine trials to improve Gag, Pol, Nef and Env specific immune responses
by: Wagner R, et al.
Published: (2009-10-01)

Effects of reduced gag cleavage efficiency on HIV-1 Gag-Pol package
by: Yi-Ru Lin, et al.
Published: (2022-04-01)

HIV Pol inhibits HIV budding and mediates the severe budding defect of Gag-Pol.
by: Xin Gan, et al.
Published: (2012-01-01)

P19-47. Novel adenovirus type 5 vaccine platform induces cellular immunity against HIV-1 Gag, Pol, Nef despite the presence of Ad5 immunity
by: Balint JP, et al.
Published: (2009-10-01)

Lower viral loads and slower CD4 decline in MRKAd5 HIV-1 vaccinees expressing disease-susceptible HLA-B*58:02
by: Leitman, E, et al.
Published: (2016)

Determination of the relative amounts of Gag and Pol proteins in foamy virus particles
by: Herchenröder Ottmar, et al.
Published: (2005-07-01)

HIV-1 Gag, Pol, and Env diversified with limited adaptation since the 1980s
by: Eric Lewitus, et al.
Published: (2024-03-01)

HIV-1 Mutant Assembly, Processing and Infectivity Expresses Pol Independent of Gag
by: Fu-Hsien Yu, et al.
Published: (2020-01-01)

Potent nonnucleoside reverse transcriptase inhibitors target HIV-1 Gag-Pol.
by: Anna Figueiredo, et al.
Published: (2006-11-01)

N-myristoyltransferase1 and N-myristoyltransferase2 Exhibit Differential Substrate Specificity for HIV-Gag and HIV-Nef
by: Smith Charles, et al.
Published: (2005-12-01)

Orthoretroviral-like prototype foamy virus gag-pol expression is compatible with viral replication
by: Reh Juliane, et al.
Published: (2011-08-01)

Expression of Gag and Pol from reconstructed HERV-Fc1, associated with multiple sclerosis
by: Nexø Bjørn A, et al.
Published: (2011-10-01)

P20-18. Diversity of Gag and Nef immunodominant regions in Brazilian HIV-1 B and F1 subtypes
by: Morgado MG, et al.
Published: (2009-10-01)

HIV-1 Escape from an HLA-B*13-Restricted Gag Epitope Affects the Gag-Pol Frameshift Stem-loop and Reduces Viral Fitness
by: Prado, J, et al.
Published: (2008)

Mouse APOBEC3 interferes with autocatalytic cleavage of murine leukemia virus Pr180gag-pol precursor and inhibits Pr65gag processing.
by: Yoshiyuki Hakata, et al.
Published: (2019-12-01)

Gag-Pol processing during HIV-1 virion maturation: a systems biology approach.
by: Balázs Könnyű, et al.
Published: (2013-01-01)

Posthumous tribute to Professor Bernardo Gontijo (08.06.1952 - 01.06-2022)
by: Everton Carlos Siviero do Vale, et al.
Published: (2023-04-01)

A large extension to HIV-1 Gag, like Pol, has negative impacts on virion assembly.
by: Hiyori Haraguchi, et al.
Published: (2012-01-01)

Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set
by: Peter Hayes, et al.
Published: (2021-01-01)

Breadth of CD8 T-cell mediated inhibition of replication of diverse HIV-1 transmitted-founder isolates correlates with the breadth of recognition within a comprehensive HIV-1 Gag, Nef, Env and Pol potential T-cell epitope (PTE) peptide set.
by: Peter Hayes, et al.
Published: (2021-01-01)

Correction: A Large Extension to HIV-1 Gag, Like Pol, Has Negative Impacts on Virion Assembly.
by: PLOS ONE Staff
Published: (2015-01-01)

Distinct transcriptome profiles of Gag-specific CD8+ T cells temporally correlated with the protection elicited by SIVΔnef live attenuated vaccine.
by: Wuxun Lu, et al.
Published: (2017-01-01)

The recognition of HIV-1 consensus group M Gag and Nef peptide reagents in mono- and multi-clade epidemics: implications for HIV vaccine design
by: Zembe L, et al.
Published: (2012-09-01)

Profesor dr hab. Zofia Kurnatowska (9.06.1932–11.08.2013) = Professor Dr. Zofia Kurnatowska (9.06.1932–11.08.2013)
by: Andrzej Buko
Published: (2013-01-01)

Host genetics and HIV-1: the final phase?
by: Jacques Fellay, et al.
Published: (2010-10-01)

The R region found in the human foamy virus long terminal repeat is critical for both Gag and Pol protein expression.
by: Russell, R, et al.
Published: (2001)

Efficacious early antiviral activity of HIV Gag- and Pol-specific HLA-B 2705-restricted CD8+ T cells.
by: Payne, R, et al.
Published: (2010)

Human Transbodies to Reverse Transcriptase Connection Subdomain of HIV-1 Gag-Pol Polyprotein Reduce Infectiousness of the Virus Progeny
by: Watee Seesuay, et al.
Published: (2021-08-01)

PP 8.3 – 00049 Reduction in Markers of HIV Persistence with Gag/Pol/Il-12 DNA Therapeutic Vaccination
by: K. Chew, et al.
Published: (2022-12-01)

The initial step in human immunodeficiency virus type 1 GagProPol processing can be regulated by reversible oxidation.
by: Sarah I Daniels, et al.
Published: (2010-10-01)

Immunogenicity of seven new recombinant yellow fever viruses 17D expressing fragments of SIVmac239 Gag, Nef, and Vif in Indian rhesus macaques.
by: Mauricio A Martins, et al.
Published: (2013-01-01)

Comparison of HIV-1 nef and gag Variations and Host HLA Characteristics as Determinants of Disease Progression among HIV-1 Vertically Infected Kenyan Children.
by: Matilda Chelimo Saina, et al.
Published: (2015-01-01)

NINA IVANOVNA TIKHOMIROVA (14. 06. 1939 — 08. 02. 2013)
Published: (2016-02-01)

Genovaitė Tėvelytė-Raguotienė (1931 06 27–2022 08 19)
by: Arvydas Pacevičius
Published: (2022-12-01)